Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19—Why Should Screening for Cardiovascular Diseases Be Performed? Reply to Vankrunkelsven, P. Tendentious Paper—Titles and Wrong Conclusions Lead to Fear in the Population and Medical Overconsumption. Comment on "Luchian et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics 2022, 12 , 57"

Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19 - Why Should Screening for Cardiovascular Diseases Be Performed? The presence of persistent dyspnea was observed in one-third of the recovered COVID-19 patients, in line with the current data on the long-term evolution of COVID-19 [[3]]. A total of 66 COVID-19 patients without a previous history of cardiorespiratory diseases were evaluated at 12 months for potential subclinical cardiac dysfunction following the acute infection [[2]]. [Extracted from the article]